Cargando…
Single tranexamic acid dose to reduce perioperative morbidity in primary total hip replacement: a randomised clinical trial
INTRODUCTION: Although prophylactic tranexamic acid (TXA) is a safe, low-cost option to reduce bleeding in patients undergoing total hip replacement (THR), its optimal dose and duration is unknown. We compared the safety and effectiveness of TXA given as either a single injection or continuous infus...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159839/ https://www.ncbi.nlm.nih.gov/pubmed/24062227 http://dx.doi.org/10.5301/hipint.5000090 |